1. Home
  2. NXDT vs SRZN Comparison

NXDT vs SRZN Comparison

Compare NXDT & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NXDT

NexPoint Diversified Real Estate Trust

HOLD

Current Price

$5.47

Market Cap

259.1M

Sector

Finance

ML Signal

HOLD

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$20.10

Market Cap

271.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXDT
SRZN
Founded
2012
2015
Country
United States
United States
Employees
N/A
44
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.1M
271.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NXDT
SRZN
Price
$5.47
$20.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
157.8K
176.5K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
9.66%
N/A
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$75.35
Revenue Next Year
N/A
N/A
P/E Ratio
$5.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$8.70
52 Week High
$5.95
$35.00

Technical Indicators

Market Signals
Indicator
NXDT
SRZN
Relative Strength Index (RSI) 55.41 34.60
Support Level $4.35 $16.75
Resistance Level $5.57 $21.40
Average True Range (ATR) 0.23 1.78
MACD -0.00 -0.16
Stochastic Oscillator 43.75 6.36

Price Performance

Historical Comparison
NXDT
SRZN

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is an externally advised REIT focused on the acquisition, asset management, development, and disposition of opportunistic, value-add investments in real estate properties throughout the United States. The company has two reportable segments: The Diversified reportable segment is focused on investing in various commercial real estate property types and across the capital structure, including but not limited to, equity, mortgage, debt, mezzanine debt and preferred equity. The Hospitality segment is focused on operating and renovating its U.S. located hospitality assets that meet its investment objective and criteria. Its Portfolio includes investments in the single-family rental, self-storage, office, hospitality, life science and multifamily sectors.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Share on Social Networks: